Using quality improvement to implement consensus guidelines for postnatal steroid treatment of preterm infants with

Taylor P Hansen1, Alexandra Oschman2, Eugenia K Pallotto1,3

  • 1Division of Neonatology, Children's Mercy Kansas City, Kansas City, MO, USA.

Insights

Adherence to consensus guidelines for postnatal steroids (PNS) in preterm infants with bronchopulmonary dysplasia (BPD) exceeded 90% within six months. Quality improvement methods successfully increased compliance and timely PNS treatment initiation without increasing repeat steroid courses.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Quality Improvement Science

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant concern in preterm infants.
  • Postnatal steroid (PNS) use for BPD requires adherence to established guidelines.
  • Variability in guideline adherence can impact infant outcomes.

Purpose of the Study:

  • To implement and assess adherence to consensus guidelines for postnatal steroid (PNS) use in preterm infants with bronchopulmonary dysplasia (BPD).
  • To improve the rate of compliance with established clinical guidelines for BPD management.

Main Methods:

  • A multidisciplinary team developed and implemented consensus guidelines for PNS use.
  • The Plan-Do-Study-Act (PDSA) quality improvement methodology was employed.
  • Key measures included guideline compliance, age of PNS initiation, and repeat steroid course rates.

Main Results:

  • Baseline compliance with PNS guidelines was 71% prior to intervention.
  • Following implementation, compliance increased to 96% within six months.
  • The rate of PNS treatment within 30 days of life increased from 50% to 80%, with no change in repeat steroid use.

Conclusions:

  • Simple quality improvement interventions can rapidly achieve high compliance with BPD treatment guidelines.
  • These findings demonstrate the effectiveness of structured approaches in clinical practice.
  • Further research is warranted to evaluate the long-term clinical impact of these guideline adherence improvements.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
588
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
130
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
926